BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19705800)

  • 1. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
    Tchabo NE; Mhawech-Fauceglia P; Caballero OL; Villella J; Beck AF; Miliotto AJ; Liao J; Andrews C; Lele S; Old LJ; Odunsi K
    Cancer Immun; 2009 Aug; 9():6. PubMed ID: 19705800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
    Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
    John T; Caballero OL; Svobodová SJ; Kong A; Chua R; Browning J; Fortunato S; Deb S; Hsu M; Gedye CA; Davis ID; Altorki N; Simpson AJ; Chen YT; Monk M; Cebon JS
    Clin Cancer Res; 2008 Jun; 14(11):3291-8. PubMed ID: 18519755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
    Tammela J; Jungbluth AA; Qian F; Santiago D; Scanlan MJ; Keitz B; Driscoll D; Rodabaugh K; Lele S; Old LJ; Odunsi K
    Cancer Immun; 2004 Oct; 4():10. PubMed ID: 15487888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors.
    Garcia-Soto AE; Schreiber T; Strbo N; Ganjei-Azar P; Miao F; Koru-Sengul T; Simpkins F; Nieves-Neira W; Lucci J; Podack ER
    Gynecol Oncol; 2017 Jun; 145(3):413-419. PubMed ID: 28392126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
    Tammela J; Uenaka A; Ono T; Noguchi Y; Jungbluth AA; Mhawech-Fauceglia P; Qian F; Schneider S; Sharma S; Driscoll D; Lele S; Old LJ; Nakayama E; Odunsi K
    Int J Oncol; 2006 Oct; 29(4):903-10. PubMed ID: 16964386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
    Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
    Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses.
    Silva WA; Gnjatic S; Ritter E; Chua R; Cohen T; Hsu M; Jungbluth AA; Altorki NK; Chen YT; Old LJ; Simpson AJ; Caballero OL
    Cancer Immun; 2007 Nov; 7():18. PubMed ID: 17983203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
    Sharma S; Qian F; Keitz B; Driscoll D; Scanlan MJ; Skipper J; Rodabaugh K; Lele S; Old LJ; Odunsi K
    Gynecol Oncol; 2005 Oct; 99(1):183-8. PubMed ID: 16005946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAGE-A3 is highly expressed in a subset of colorectal cancer patients.
    Shantha Kumara HM; Grieco MJ; Caballero OL; Su T; Ahmed A; Ritter E; Gnjatic S; Cekic V; Old LJ; Simpson AJ; Cordon-Cardo C; Whelan RL
    Cancer Immun; 2012; 12():16. PubMed ID: 23390371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
    Valmori D; Qian F; Ayyoub M; Renner C; Merlo A; Gnjatic S; Stockert E; Driscoll D; Lele S; Old LJ; Odunsi K
    Clin Cancer Res; 2006 Jan; 12(2):398-404. PubMed ID: 16428478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAC1: biology and potential application in cancer immunotherapy.
    Mahmoudian J; Ghods R; Nazari M; Jeddi-Tehrani M; Ghahremani MH; Ghaffari-Tabrizi-Wizsy N; Ostad SN; Zarnani AH
    Cancer Immunol Immunother; 2019 Jul; 68(7):1039-1058. PubMed ID: 31165204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers.
    Devor EJ; Gonzalez-Bosquet J; Warrier A; Reyes HD; Ibik NV; Schickling BM; Newtson A; Goodheart MJ; Leslie KK
    Int J Oncol; 2017 May; 50(5):1721-1728. PubMed ID: 28339050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta-specific 1.
    Ghods R; Ghahremani MH; Darzi M; Mahmoudi AR; Yeganeh O; Bayat AA; Pasalar P; Jeddi-Tehrani M; Zarnani AH
    Biotechnol Appl Biochem; 2014; 61(3):363-9. PubMed ID: 24237073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients.
    Dong XY; Peng JR; Ye YJ; Chen HS; Zhang LJ; Pang XW; Li Y; Zhang Y; Wang S; Fant ME; Yin YH; Chen WF
    Int J Cancer; 2008 May; 122(9):2038-43. PubMed ID: 18183594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPPA2 Protein Expression is Associated with Gastric Cancer Metastasis.
    Shabestarian H; Ghodsi M; Mallak AJ; Jafarian AH; Montazer M; Forghanifard MM
    Asian Pac J Cancer Prev; 2015; 16(18):8461-5. PubMed ID: 26745102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.